Search research articles
Contact Us
Filters
Showing results (51-60 of 162) with videos related to
Page
of 17
Sort By:
American Journal of Clinical Oncology
|
December 1, 1995
Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer
J N Ingle, J E Krook, J A Mailliard, et al.
Cancer Treatment Reports
|
August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung
J C Britell, R T Eagan, J N Ingle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2009
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, J N Ingle, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2020
Reply to Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?
A S Coates, A Goldhirsch, R D Gelber, et al.
Cancer Treatment Reports
|
January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer
R T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports
|
May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer
R T Eagan, S Frytak, W C Nichols, et al.
Oncology
|
January 1, 1980
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer
J Rubin, D A Decker, D L Ahmann, et al.
Cancer Treatment Reports
|
January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancer
W C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials
|
January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapy
R T Eagan, T R Fleming, R E Lee, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 162) with videos related to
Sort By:
Page
of 17
American Journal of Clinical Oncology
|
December 1, 1995
Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer
J N Ingle, J E Krook, J A Mailliard, et al.
Cancer Treatment Reports
|
August 1, 1978
cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung
J C Britell, R T Eagan, J N Ingle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2009
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, J N Ingle, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 21, 2020
Reply to Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?
A S Coates, A Goldhirsch, R D Gelber, et al.
Cancer Treatment Reports
|
January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer
R T Eagan, T R Fleming, S Frytak, et al.
Cancer Treatment Reports
|
May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer
R T Eagan, S Frytak, W C Nichols, et al.
Oncology
|
January 1, 1980
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer
J Rubin, D A Decker, D L Ahmann, et al.
Cancer Treatment Reports
|
January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancer
W C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials
|
January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
R T Eagan, S Frytak, R E Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapy
R T Eagan, T R Fleming, R E Lee, et al.
Page
of 17